VYCOR MEDICAL INC Income Statement
VYCO|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
VYCOR MEDICAL INC reported $2M in revenue and $72,426 in net loss for FY2025. Revenue has grown at a 4.8% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -35.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.9M | $1.6M | $1.5M | $1.2M | $1.4M | $1.1M | $1.4M | $1.5M | $1.4M | $1.5M | $1.1M | $1.3M | $1.1M | $1.2M | $971.4K |
| Cost of Revenue | $302.3K | $166.8K | $144.9K | $140.6K | $134.7K | $132.5K | $134.8K | $169.6K | $227.1K | $184.7K | $164.1K | $156.3K | $153.8K | $179.5K | $176.3K |
| Gross Profit | $1.6M | $1.4M | $1.3M | $1.1M | $1.3M | $1.0M | $1.3M | $1.3M | $1.2M | $1.3M | $974.5K | $1.1M | $935.5K | $1.0M | $795.1K |
| SG&A Expense | $1.5M | $1.4M | $1.2M | $1.3M | $1.6M | $1.7M | $1.8M | $2.2M | $2.2M | $2.6M | $2.5M | $3.4M | $2.8M | $3.4M | $5.0M |
| R&D Expense | $10.0K | $15.3K | $22.6K | - | $15.2K | $0 | $0 | - | $3.0K | $4.7K | $71.5K | $69.1K | $53.5K | $126.0K | $115.7K |
| Operating Income | $33.9K | -$9.1K | $40.2K | -$306.5K | -$436.0K | -$727.4K | -$601.4K | -$1.3M | -$1.3M | -$1.6M | -$2.0M | -$2.7M | -$2.3M | -$2.8M | -$4.6M |
| Interest Expense | - | - | - | - | - | - | - | - | - | $13.2K | - | - | - | $13.2K | $127.1K |
| Net Income | -$72.4K | -$107.2K | -$69.7K | -$404.9K | -$435.7K | -$822.5K | -$796.2K | -$1.4M | -$1.5M | -$1.7M | -$2.1M | -$4.0M | -$2.4M | -$2.9M | -$4.8M |
| EPS (Basic) | -$0.01 | -$0.01 | -$0.01 | -$0.02 | - | - | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$0.01 | -$0.01 | -$0.01 | -$0.02 | -$0.04 | -$0.04 | -$0.05 | -$0.08 | -$0.10 | -$0.20 | -$0.20 | -$0.39 | -$0.39 | -$0.92 | -$0.00 |
| Shares Outstanding | 33.4M | 33.4M | 32.6M | 32.5M | 27.4M | 27.4M | 25.3M | 23.1M | 19.8M | 10.9M | 10.9M | 6.6M | 6.8M | 5.4M | 724.5M |
| Gross Margin | 83.8% | 89.5% | 90.1% | 88.5% | 90.3% | 88.4% | 90.3% | 88.8% | 83.6% | 87.3% | 85.6% | 87.5% | 85.9% | 85.1% | 81.8% |
| Operating Margin | 1.8% | -0.6% | 2.8% | -25.1% | -31.3% | -63.7% | -43.2% | -87.3% | -94.8% | -109.5% | -174.9% | -218.5% | -209.4% | -231.8% | -476.4% |
| Profit Margin | -3.9% | -6.8% | -4.8% | -33.1% | -31.3% | -72.0% | -57.2% | -91.4% | -106.7% | -113.7% | -182.9% | -323.9% | -224.4% | -243.2% | -491.9% |